Home
In this issue
April 21, 2014

Andrew Silow-Carroll: Passoverkill? Suggestions to make next year's seders even more culturally sensitive

Sara Israelsen Hartley: Seeking the Divine: An ancient connection in a new context

Christine M. Flowers: Priest's execution in Syria should be call to action

Courtnie Erickson: How to help kids accept the poor decisions of others

Lizette Borreli: A Glass Of Milk A Day Keeps Knee Arthritis At Bay

Lizette Borreli: 5 Health Conditions Your Breath Knows Before You Do

The Kosher Gourmet by Betty Rosbottom Coconut Walnut Bars' golden brown morsels are a beautifully balanced delectable delight

April 18, 2014

Rabbi Yonason Goldson: Clarifying one of the greatest philosophical conundrums in theology

Caroline B. Glick: The disappearance of US will

Megan Wallgren: 10 things I've learned from my teenagers

Lizette Borreli: Green Tea Boosts Brain Power, May Help Treat Dementia

John Ericson: Trying hard to be 'positive' but never succeeding? Blame Your Brain

The Kosher Gourmet by Julie Rothman Almondy, flourless torta del re (Italian king's cake), has royal roots, is simple to make, . . . but devour it because it's simply delicious

April 14, 2014

Rabbi Dr Naftali Brawer: Passover frees us from the tyranny of time

Greg Crosby: Passing Over Religion

Eric Schulzke: First degree: How America really recovered from a murder epidemic

Georgia Lee: When love is not enough: Teaching your kids about the realities of adult relationships

Cameron Huddleston: Freebies for Your Lawn and Garden

Gordon Pape: How you can tell if your financial adviser is setting you up for potential ruin

Dana Dovey: Up to 500,000 people die each year from hepatitis C-related liver disease. New Treatment Has Over 90% Success Rate

Justin Caba: Eating Watermelon Can Help Control High Blood Pressure

The Kosher Gourmet by Joshua E. London and Lou Marmon Don't dare pass over these Pesach picks for Manischewitz!

April 11, 2014

Rabbi Hillel Goldberg: Silence is much more than golden

Caroline B. Glick: Forgetting freedom at Passover

Susan Swann: How to value a child for who he is, not just what he does

Cameron Huddleston: 7 Financial Tasks You Should Tackle Right Now

Sandra Block and Lisa Gerstner: How to Profit From Your Passion

Susan Scutti: A Simple Blood Test Might Soon Diagnose Cancer

Chris Weller: Have A Slow Metabolism? Let Science Speed It Up For You

The Kosher Gourmet by Diane Rossen Worthington Whitefish Terrine: A French take on gefilte fish

April 9, 2014

Jonathan Tobin: Why Did Kerry Lie About Israeli Blame?

Samuel G. Freedman: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Jessica Ivins: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Kim Giles: Asking for help is not weakness

Kathy Kristof and Barbara Hoch Marcus: 7 Great Growth Israeli Stocks

Matthew Mientka: How Beans, Peas, And Chickpeas Cleanse Bad Cholesterol and Lowers Risk of Heart Disease

Sabrina Bachai: 5 At-Home Treatments For Headaches

The Kosher Gourmet by Daniel Neman Have yourself a matzo ball: The secrets bubby never told you and recipes she could have never imagined

April 8, 2014

Lori Nawyn: At Your Wit's End and Back: Finding Peace

Susan B. Garland and Rachel L. Sheedy: Strategies Married Couples Can Use to Boost Benefits

David Muhlbaum: Smart Tax Deductions Non-Itemizers Can Claim

Jill Weisenberger, M.S., R.D.N., C.D.E : Before You Lose Your Mental Edge

Dana Dovey: Coffee Drinkers Rejoice! Your Cup Of Joe Can Prevent Death From Liver Disease

Chris Weller: Electric 'Thinking Cap' Puts Your Brain Power Into High Gear

The Kosher Gourmet by Marlene Parrish A gift of hazelnuts keeps giving --- for a variety of nutty recipes: Entree, side, soup, dessert

April 4, 2014

Rabbi David Gutterman: The Word for Nothing Means Everything

Charles Krauthammer: Kerry's folly, Chapter 3

Amy Peterson: A life of love: How to build lasting relationships with your children

John Ericson: Older Women: Save Your Heart, Prevent Stroke Don't Drink Diet

John Ericson: Why 50 million Americans will still have spring allergies after taking meds

Cameron Huddleston: Best and Worst Buys of April 2014

Stacy Rapacon: Great Mutual Funds for Young Investors

Sarah Boesveld: Teacher keeps promise to mail thousands of former students letters written by their past selves

The Kosher Gourmet by Sharon Thompson Anyone can make a salad, you say. But can they make a great salad? (SECRETS, TESTED TECHNIQUES + 4 RECIPES, INCLUDING DRESSINGS)

April 2, 2014

Paul Greenberg: Death and joy in the spring

Dan Barry: Should South Carolina Jews be forced to maintain this chimney built by Germans serving the Nazis?

Mayra Bitsko: Save me! An alien took over my child's personality

Frank Clayton: Get happy: 20 scientifically proven happiness activities

Susan Scutti: It's Genetic! Obesity and the 'Carb Breakdown' Gene

Lecia Bushak: Why Hand Sanitizer May Actually Harm Your Health

Stacy Rapacon: Great Funds You Can Own for $500 or Less

Cameron Huddleston: 7 Ways to Save on Home Decor

The Kosher Gourmet by Steve Petusevsky Exploring ingredients as edible-stuffed containers (TWO RECIPES + TIPS & TECHINQUES)

Jewish World Review

5 Cheap Stocks Ready to Take Off

By Tom Petruno





These market laggards have the potential to pay off big if investors' pessimism proves to be overblown


JewishWorldReview.com | To find bargains in the stock market, you often have to go where investors fear to tread. That's especially true in the current bull market, which has seen share prices triple, on average, since stocks bottomed in March 2009.

To identify cheap stocks, we specifically looked for names that are trading far below their 2011 peaks, when the latest charge of the bull market began. We found five especially attractive companies. All of them face big challenges, so the stocks are risky. But that risk comes with the potential for hefty payoffs if it turns out that investors have been too pessimistic about the companies' prospects. (Prices and other data are through April 30.)

AMBITIOUS CHIP MAKER

If you invested in tech the past few years, you probably made out well--unless you owned shares of Broadcom (symbol BRCM). The Irvine, Cal., firm, a powerhouse in semiconductors for wireless devices, TV set-top boxes and other applications, has been spending big to develop new chips to take on wireless-tech kingpin Qualcomm. Broadcom wants to smash Qualcomm's dominance in "baseband" technology, which is at the heart of wireless phones, as the industry moves to the next generation of faster chips.

Critics say Broadcom is fighting an unwinnable war against Qualcomm, wasting much of its research spending in the effort. The firm has shelled out $8.6 billion since 2010, and that has helped depress earnings. Profits fell to 86 cents per share last year, from $1.25 in 2012, even as sales rose 4%, to a record $8.3 billion.

But bulls say the market is underestimating Broadcom's firepower across the broad spectrum of tech "connectivity"--the linking of everything electronic in the years to come. The company likes to say that 99.98% of all Internet traffic now crosses at least one Broadcom chip. As for the Qualcomm challenge, analysts at brokerage Jefferies Group see it as a win-win situation: Broadcom has reached the point at which it will either succeed soon, fueling earnings growth, or pull the plug and save a bundle on further research.

A BET ON CANADIAN ENERGY

Western Canada is loaded with oil, but that crude has run into transportation bottleĀnecks getting to the U.S. and other markets in recent years. The result: depressed prices for Canadian energy--and for stocks of energy producers such as Canadian Natural Resources (CNQ).

The situation began to change late last year with the opening of new rail transport lines. Construction of new pipelines will also help. Energy companies north of the border would get an especially large boost if the Obama administration were to approve the controversial Keystone XL pipeline, which would take western Canadian oil to ports on the Gulf of Mexico. (It appears that President Obama won't make a final decision until after the November elections.)

A rise in Canadian oil prices this year has helped lift Canadian Natural Resources' shares lately. But analysts at brokerage Canaccord Genuity say the stock price doesn't yet reflect the improved outlook. In a sign that executives are confident about the future, the company--which last year earned $2.1 billion, or $1.89 per share, on revenues of $16.3 billion--boosted its quarterly dividend by 12.5% in March, after hiking it 60% in November (figures are in U.S. dollars). Brokerage RBC Capital, which calls Canadian Natural its favorite oil-and-gas producer, sees the company as a major long-term beneficiary of more western Canadian crude making its way to global markets.

SHOEMAKER WITH LEGS

Wall Street is notorious for punishing companies that are willing to sacrifice earnings in the short run for potential long-term gains. That's part of what's been weighing lately on the shares of footwear firm Deckers Outdoor (DECK).

The maker of Ugg, Teva, Sanuk and other upscale shoe brands reported stellar earnings for the fourth quarter of 2013--up 46% from a year earlier, on a 19% rise in sales. But the Goleta, Cal., company also lowered profit expectations for the first half of 2014, citing among other things the cost of its continuing push to open more retail stores worldwide. Some analysts, including Corinna Freedman, of Wedbush Securities, think investors are being too shortsighted.Ā Freedman expects sales in 2014 to rise 11%, to $1.7 billion, and earnings to climb 12%, to $4.65 per share.

Because it is free of debt, Deckers has a lot of financial flexibility. But it remains heavily dependent on its pricey Ugg footwear, which accounts for 83% of sales. The stock collapsed in 2012, when Ugg sales slipped 2% for the year and earnings slid 32%. But Ugg sales surged 19% in the fourth quarter of 2013 and 10% for the year. Deckers expects to use its growing base of retail stores to complement sales via other retailers and online. And it sees foreign markets--especially Asia--as hot growth areas. If the Ugg brand still has legs, so does Deckers stock.

MATTRESS MAKER FIRMS UP

Tempur Sealy International (TPX) is trying to buy its way back to growth in the competitive mattress business. But so far, many investors have hit the snooze button.

The Lexington, Ky., company, then known as Tempur-Pedic International, rode the popularity of memory-foam mattresses to great success from 2009 to 2012, and its shares soared from less than $10 to a peak of $87. But vicious competition in the foam-mattress segment led to slowing sales and slumping profits in 2012. That drove Tempur to snap up rival Sealy Corp., a deal that CEO Mark Sarvary promised would create "tremendous value" for shareholders. The combined company's sales hit $2.5 billion in 2013, making it the world's biggest bedding maker. But earnings haven't lived up to projections.

Sealy broadens the company's line of mattresses. But Sealy's lower-priced mattresses have lower profit margins than Tempur's higher-end memory-foam bedding, at a time when Tempur needs more cash to whittle down a $1.8 billion debt load bloated by the merger. Still, KeyBanc Capital Markets says Tempur is experiencing an "exciting transformation" driven by new products, expansion overseas and cost-cutting. Analysts see profits surging 22% in 2015. That kind of growth should help Temper shares emerge from their slumber.


FREE SUBSCRIPTION TO INFLUENTIAL NEWSLETTER

Every weekday JewishWorldReview.com publishes what many in the media and Washington consider "must-reading". In addition to INSPIRING stories, HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here.


ON THE WATCH LIST

Weight loss is a growth industry, which ought to mean great times for Weight Watchers International (WTW). But the firm's fortunes have faded badly over the past two years. Revenue is expected to total $1.4 billion this year, down from a peak of $1.8 billion in 2012. Earnings are expected to come in at just $1.40 per share this year, compared with $4.23 in 2012. The stock has plunged from a high of $87 in May 2011 to $20.

Executives were slow to realize the increasing threat posed by free diet-plan mobile applications. Meanwhile, the company loaded up on debt to pay for stock buybacks. That double whammy leaves the New York City firm facing a very real threat of oblivion.

But Morningstar analyst R.J. Hottovy thinks new CEO Jim Chambers is taking the right steps to revive the franchise. That includes meshing the firm's meal regimen and fee-generating dieter-support meetings with new online and mobile applications. The key, Hottovy says, is that, unlike so many other diet programs, Weight Watchers' plans have been proven to work. If the 50-year-old firm can reinforce its message with consumers, employers and health plans in the U.S. and abroad, it could grab back market share.

Sign up for the daily JWR update. It's free. Just click here.

Interested in a private Judaic studies instructor — for free? Let us know by clicking here.

Tom Petruno is a Contributing Writer for Kiplinger's Personal Finance magazine.



All contents copyright 2013 The Kiplinger Washington Editors, Inc. Distributed by Tribune Content Agency, LLC

Quantcast